PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.5000
-0.0100 (-1.96%)
At close: Jul 10, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 87.04 million as of July 10, 2026. Its market cap has increased by 50.99% in one year.
Market Cap
87.04M
Enterprise Value
68.57M
Revenue
24.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 87.04M, an increase of 3,526.70%. That is a compound annual growth rate of 158.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 87.04M | 14.60% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 8.72B |
| Extendicare | 3.50B |
| Sienna Senior Living | 2.44B |
| Green Thumb Industries | 2.29B |
| Zentek | 84.84M |
| Leef Brands | 82.45M |
| Theralase Technologies | 79.83M |
| NetraMark Holdings | 76.05M |